NDC 0005-0100
Trumenba
Meningococcal Group B Vaccine
Trumenba is a Intramuscular Injection, Suspension in the Vaccine category. It is labeled and distributed by Wyeth Pharmaceutical Division Of Wyeth Holdings Llc. The primary component is Neisseria Meningitidis Group B Recombinant Lp2086 A05 Protein Variant Antigen; Neisseria Meningitidis Group B Recombinant Lp2086 B01 Protein Variant Antigen.
| Product ID | 0005-0100_22901610-8dae-4fd8-9c3c-292eadc93662 |
| NDC | 0005-0100 |
| Product Type | Vaccine |
| Proprietary Name | Trumenba |
| Generic Name | Meningococcal Group B Vaccine |
| Dosage Form | Injection, Suspension |
| Route of Administration | INTRAMUSCULAR |
| Marketing Start Date | 2014-11-05 |
| Marketing Category | BLA / BLA |
| Application Number | BLA125549 |
| Labeler Name | Wyeth Pharmaceutical Division of Wyeth Holdings LLC |
| Substance Name | NEISSERIA MENINGITIDIS GROUP B RECOMBINANT LP2086 A05 PROTEIN VARIANT ANTIGEN; NEISSERIA MENINGITIDIS GROUP B RECOMBINANT LP2086 B01 PROTEIN VARIANT ANTIGEN |
| Active Ingredient Strength | 60 ug/.5mL; ug/.5mL |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
Packaging
NDC 0005-0100-02
1 SYRINGE in 1 CARTON (0005-0100-02) > .5 mL in 1 SYRINGE (0005-0100-01)
| Marketing Start Date | 2014-11-05 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 0005-0100-05 [00005010005]
TRUMENBA INJECTION, SUSPENSION
| Marketing Category | BLA |
| Application Number | BLA125549 |
| Product Type | VACCINE |
| Billing Unit | ML |
| Marketing Start Date | 2014-11-05 |
NDC 0005-0100-01 [00005010001]
TRUMENBA INJECTION, SUSPENSION
| Marketing Category | BLA |
| Application Number | BLA125549 |
| Product Type | VACCINE |
| Billing Unit | ML |
| Marketing Start Date | 2014-11-05 |
NDC 0005-0100-10 [00005010010]
TRUMENBA INJECTION, SUSPENSION
| Marketing Category | BLA |
| Application Number | BLA125549 |
| Product Type | VACCINE |
| Billing Unit | ML |
| Marketing Start Date | 2014-11-05 |
NDC 0005-0100-02 [00005010002]
TRUMENBA INJECTION, SUSPENSION
| Marketing Category | BLA |
| Application Number | BLA125549 |
| Product Type | VACCINE |
| Marketing Start Date | 2018-02-01 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| NEISSERIA MENINGITIDIS GROUP B RECOMBINANT LP2086 A05 PROTEIN VARIANT ANTIGEN | 60 ug/.5mL |
Trademark Results [Trumenba]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 TRUMENBA 85035452 4384268 Live/Registered |
Wyeth LLC 2010-05-11 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.